Home › Prostate Cancer › Florida › Miami
Prostate Cancer clinical trials in Miami, FL
30 studies for Prostate Cancer are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Recruiting
- University of Miami, Miami
WATER IV PCa (AS Sub-study)
Recruiting
- University of Miami, Miami
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials
RecruitingObservational studyHealthy volunteers welcome
- University of Miami, Miami
Testosterone Replacement Therapy in Hypogonadal Patients With Prostate Cancer Under Active Surveillance
RecruitingPhase 4
- Desai Sethi Urology Institute, Miami
- Sylvester Comprehensive Cancer Center, Miami
A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Biogenix Molecular, LLC, Miami
A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors
RecruitingPhase 1
- Biogenix Molecular, LLC, Miami
Exercise-induced Steroid Changes in Active Surveillance for Prostate Cancer
Recruiting
- University of Miami Hospitals and Clinics, Miami
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
RecruitingPhase 1
- Sylvester Comprehensive Cancer Center, Miami
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
RecruitingPhase 3
- Research Site, Miami
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
RecruitingPhase 1
- Research Site, Miami
Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
RecruitingPhase 1/2
- Sylvester Comprehensive Cancer Center - University of Miami Health System, Miami
Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)
RecruitingPhase 3
- Research Site, Miami
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
RecruitingPhase 3
- Baptist Health South, Miami
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
RecruitingPhase 1/2
- Research Site, Miami
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
RecruitingPhase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RecruitingPhase 1/2
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RecruitingHealthy volunteers welcome
- University of Miami, Miami
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
RecruitingPhase 2/3
- Baptist Health South, Miami
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
RecruitingPhase 3
- Biogenix Molecular, LLC, Miami
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
RecruitingPhase 1/2
- Mount Sinai Medical Center, Miami
A Study of FG-3246 in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
RecruitingPhase 2
- Biogenix Molecular, LLC, Miami
Assessing Efficacy of Neoadjuvant ADT in Localized High-Risk Prostate Cancer Patients Utilizing 18F-Flotufolastat PSMA PET/CT
RecruitingPhase 2
- Miami Cancer Institute at Baptist Health, Inc., Miami
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
RecruitingPhase 3
- University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
- UM Sylvester Comprehensive Cancer Center at Kendall, Miami
PSMA-Directed Para-Aortic Radiation Therapy for Oligorecurrent Prostate Cancer
RecruitingPhase 2
- University of Miami, Miami
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
RecruitingPhase 1/2
- Biogenix Molecular LLC, Miami
- NovaCure Health, Miami
Metabolic Impact and Compliance of Controlled, Varying, Mediterranean Diets in Pre-Surgical Prostate Cancer Populations (PROVISIONS)
Recruiting
- University of Miami, Miami
Collection and Measurement of Biomarkers in Prostate Cancer Radiotherapy Patients
RecruitingObservational study
- University of Miami, Miami
The University of Miami Adapt (UAdapt) Trial
RecruitingPhase 2
- University of Miami, Miami
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
RecruitingPhase 1
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Miami
About Prostate Cancer
Prostate cancer is one of the most common types of cancer among American men. The risk goes up as men age. Learn about symptoms, tests, and treatment.
More about Prostate Cancer on MedlinePlus
Prostate Cancer trials in other cities
- New York City, NY101 studies
- Houston, TX73 studies
- Los Angeles, CA64 studies
- Boston, MA56 studies
- Seattle, WA45 studies
- St. Louis, MO45 studies
- Chicago, IL45 studies
- Baltimore, MD45 studies
- San Francisco, CA44 studies
- Philadelphia, PA41 studies
- Nashville, TN40 studies
- Washington, DC39 studies
Other studies in Miami
- Breast Cancer42 studies
- Cancer (all types)36 studies
- Non-Small Cell Lung Cancer35 studies
- Obesity28 studies
- Ovarian Cancer24 studies
- Acute Myeloid Leukemia24 studies
- Overweight23 studies
- Metastatic Cancer22 studies
- Multiple Myeloma22 studies
- Lung Cancer22 studies
- Alzheimer's Disease21 studies
- COPD20 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.